HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Benzethonium Chloride Bioavailability, Toxicity Studies Planned By Lonza

This article was originally published in The Rose Sheet

Executive Summary

The safety of benzethonium chloride in differing vehicles will be tested through a combination of in vitro dermal penetration studies and a toxicokinetic study in rats to be conducted by Lonza, Inc.

You may also be interested in...

Benzethonium Chloride Review Urged By Lonza Before Final Monograph

FDA should complete a safety review of benzethonium chloride as a Category I active ingredient for the healthcare antiseptic products monograph before finalizing the rule, chemical ingredient supplier Lonza says in a recent letter to the agency.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts